4//SEC Filing
AKER HAZEL M 4
Accession 0001209191-20-043496
CIK 0001260990other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 5:00 PM ET
Size
7.9 KB
Accession
0001209191-20-043496
Insider Transaction Report
Form 4
AKER HAZEL M
General Counsel
Transactions
- Award
Warrants
2020-07-21$2.38/sh+20,986$49,999→ 20,986 total(indirect: By Trust)Exercise: $2.32Exp: 2026-01-21→ Common Stock (20,986 underlying) - Purchase
Common Stock
2020-07-21$2.38/sh+41,972$99,998→ 46,987 total(indirect: By Trust)
Holdings
- 4,284
Common Stock
Footnotes (1)
- [F1]The warrants are currently exercisable into shares of the Issuer's Common Stock except to the extent that the exercise would result in the beneficial ownership of more than 4.99% of the Issuer's outstanding Common Stock.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001265783
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 5:00 PM ET
- Size
- 7.9 KB